120 related articles for article (PubMed ID: 38840293)
1. Difluorinated thromboxane A
Allen MF; Hutchinson JL; Keith M; Mallah S; Corey RA; Trory JS; Jing C; Fang H; Wei L; Bennett SH; Aggarwal VK; Mundell SJ; Hers I
Br J Pharmacol; 2024 Jun; ():. PubMed ID: 38840293
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
Watts IS; Wharton KA; White BP; Lumley P
Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
[TBL] [Abstract][Full Text] [Related]
3. 1, 6-di-O-caffeoyl-β-D-glucopyranoside, a natural compound from Callicarpa nudiflora Hook impairs P2Y
Fu J; Zhu X; Wang W; Lu H; Zhang Z; Liu T; Xu H; Fu H; Ma S; Luo Y
Phytomedicine; 2017 Dec; 36():273-282. PubMed ID: 29157825
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
5. Dihydropyridine agonist Bay K 8644 inhibits platelet activation by competitive antagonism of thromboxane A2-prostaglandin H2 receptor.
Johnson GJ; Dunlop PC; Leis LA; From AH
Circ Res; 1988 Mar; 62(3):494-505. PubMed ID: 2449295
[TBL] [Abstract][Full Text] [Related]
6. Thromboxane A2 induces blood flow recovery via platelet adhesion to ischaemic regions.
Amano H; Ito Y; Eshima K; Kato S; Ogawa F; Hosono K; Oba K; Tamaki H; Sakagami H; Shibuya M; Narumiya S; Majima M
Cardiovasc Res; 2015 Sep; 107(4):509-21. PubMed ID: 25935870
[TBL] [Abstract][Full Text] [Related]
7. The novel prostaglandin I2 mimetic ONO-1301 escapes desensitization in an antiplatelet effect due to its inhibitory action on thromboxane A2 synthesis in mice.
Kashiwagi H; Yuhki K; Kojima F; Kumei S; Takahata O; Sakai Y; Narumiya S; Ushikubi F
J Pharmacol Exp Ther; 2015 May; 353(2):269-78. PubMed ID: 25740898
[TBL] [Abstract][Full Text] [Related]
8. The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha.
Kinsella BT; O'Mahony DJ; Fitzgerald GA
J Pharmacol Exp Ther; 1997 May; 281(2):957-64. PubMed ID: 9152406
[TBL] [Abstract][Full Text] [Related]
9. ZD9583, an orally effective thromboxane A2 synthase inhibitor and receptor antagonist with a sustained duration of action in rat and dog.
Brownlie RP; Brownrigg NJ; Butcher HM; Garcia R; Jessup R; Lee VJ; Tunstall S; Wayne MG
J Pharm Pharmacol; 1997 Feb; 49(2):187-94. PubMed ID: 9055193
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming Megakaryocytes for Controlled Release of Platelet-like Particles Carrying a Single-Chain Thromboxane A
Lu R; Li Y; Xu A; King B; Ruan KH
Cells; 2023 Dec; 12(24):. PubMed ID: 38132095
[TBL] [Abstract][Full Text] [Related]
11. Decrease in agonist affinity for human platelet thromboxane A2/prostaglandin H2 receptors induced by a platelet-derived supernatant.
Dorn GW; Burch RM; Kochel PJ; Mais DE; Halushka PV
Biochem Pharmacol; 1987 Jun; 36(12):1913-7. PubMed ID: 2954555
[TBL] [Abstract][Full Text] [Related]
12. Regulation of thromboxane receptor trafficking through the prostacyclin receptor in vascular smooth muscle cells: role of receptor heterodimerization.
Wilson SJ; Dowling JK; Zhao L; Carnish E; Smyth EM
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):290-6. PubMed ID: 17110599
[TBL] [Abstract][Full Text] [Related]
13. The angiotensin AT
Fredgart MH; Leurgans TM; Stenelo M; Nybo M; Bloksgaard M; Lindblad L; De Mey JGR; Steckelings UM
Peptides; 2023 Jun; 164():170990. PubMed ID: 36894067
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, Stability, and Biological Studies of Fluorinated Analogues of Thromboxane A
Jing C; Mallah S; Kriemen E; Bennett SH; Fasano V; Lennox AJJ; Hers I; Aggarwal VK
ACS Cent Sci; 2020 Jun; 6(6):995-1000. PubMed ID: 32607446
[TBL] [Abstract][Full Text] [Related]
15. Characterization of thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors of rat platelets and their interaction with TXA2/PGH2 receptor antagonists.
Hanasaki K; Arita H
Biochem Pharmacol; 1988 Oct; 37(20):3923-9. PubMed ID: 2973322
[TBL] [Abstract][Full Text] [Related]
16. Thromboxane A2/thromboxane A2 receptor axis facilitates hepatic insulin resistance and steatosis through endoplasmic reticulum stress in non-alcoholic fatty liver disease.
Dai Y; Xu R; Chen J; Fang J; Zhang H; Li H; Chen W
Br J Pharmacol; 2024 Apr; 181(7):967-986. PubMed ID: 37940413
[TBL] [Abstract][Full Text] [Related]
17. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets.
Mais DE; Kochel PJ; Saussy DL; Halushka PV
Mol Pharmacol; 1985 Aug; 28(2):163-9. PubMed ID: 2991736
[TBL] [Abstract][Full Text] [Related]
18. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
Yin K; Halushka PV; Yan YT; Wong PY
J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets.
Chang TS; Kim HM; Lee KS; Khil LY; Mar WC; Ryu CK; Moon CK
Biochem Pharmacol; 1997 Jul; 54(2):259-68. PubMed ID: 9271330
[TBL] [Abstract][Full Text] [Related]
20. Regulation of protein kinase C-related kinase (PRK) signalling by the TPα and TPβ isoforms of the human thromboxane A
O'Sullivan AG; Mulvaney EP; Kinsella BT
Biochim Biophys Acta Mol Basis Dis; 2017 Apr; 1863(4):838-856. PubMed ID: 28108419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
